Fig. 2.

Study set results. (A) Disease-free and overall survival in 58 consecutive cases from BJH, illustrated in a Kaplan–Meier plot. The mean DFS and OS in all patients are 112.2 and 114.5 months (9 y), respectively, reflecting the good response most patients have to treatment. (B) Comparison of overall survival in the high-risk (HR) and standard-risk (SR) groups (log-rank, Wilcoxon P< .001). The HR group had a mean survival time of 25.8 months (95% CI, 8.3–43.7 months), compared with 152.9 months (95% CI, 127.6–178.4 months) for the SR group.